Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Florian Kronenberg, Armin Steinmetz, Gerhard M. Kostner & Hans Dieplinger. (1996) Lipoprotein(a) in Health and Disease. Critical Reviews in Clinical Laboratory Sciences 33:6, pages 495-543.
Read now
Read now
J. W. J. Van Wersch. (1994) The behaviour of Lipoprotein(a) in patients with various diseases. Scandinavian Journal of Clinical and Laboratory Investigation 54:7, pages 559-562.
Read now
Read now
Articles from other publishers (19)
Giulia Malaguarnera, Caterina Gagliano, Claudio Bucolo, Marco Vacante, Salvatore Salomone, Michele Malaguarnera, Daniela Giovanna Leonardi, Massimo Motta, Filippo Drago & Teresio Avitabile. (2013) Lipoprotein(a) Serum Levels in Diabetic Patients with Retinopathy. BioMed Research International 2013, pages 1-5.
Crossref
Crossref
Hans-Henrik Parving, Michael Mauer, Paola Fioretto, Peter Rossing & Eberhard Ritz. 2011. Brenner and Rector's The Kidney. Brenner and Rector's The Kidney
1411
1454
.
Anoop Misra, Sumit Kumar, Naval Kishore Vikram & Atul Kumar. (2003) The Role of Lipids in the Development of Diabetic Microvascular Complications. American Journal of Cardiovascular Drugs 3:5, pages 325-338.
Crossref
Crossref
Garry X. Shen. 2003. Atherosclerosis, Hypertension and Diabetes. Atherosclerosis, Hypertension and Diabetes
289
300
.
M. B. Mattock, N. Cronin, P. Cavallo‐Perin, B. Idzior‐Walus, G. Penno, S. Bandinelli, E. Standl, A. Kofinis, J. H. Fuller & The Eurodiab Iddm Complications Study Group. (2001) Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetic Medicine 18:1, pages 59-67.
Crossref
Crossref
Jianying Zhang, Song Ren & Garry X Shen. (2000) Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells. Atherosclerosis 150:2, pages 299-308.
Crossref
Crossref
Linda Davies, Greg R Fulcher, Andrew Atkins, Kim Frumar, Judith Monaghan, Gordon Stokes, Philip Clifton-Bligh, Aidan McElduff, Bruce Robinson, John Stiel, Stephen Twigg & Errol Wilmshurst. (1999) The Relationship of Prorenin Values to Microvascular Complications in Patients with Insulin-Dependent Diabetes Mellitus. Journal of Diabetes and its Complications 13:1, pages 45-51.
Crossref
Crossref
Per-Henrik Groop. 1998. The Kidney and Hypertension in Diabetes Mellitus. The Kidney and Hypertension in Diabetes Mellitus
357
369
.
A. Van den Ende, Y.Y. van der Hoek, J.J.P. Kastelein, M.L. Koschinsky, C. Labeur & M. Rosseneu. 1996. Advances in Clinical Chemistry Volume 32. Advances in Clinical Chemistry Volume 32
73
134
.
Per-Henrik Groop. 1997. The Kidney and Hypertension in Diabetes Mellitus. The Kidney and Hypertension in Diabetes Mellitus
307
320
.
J.J. Couper, R. Cocciolone, D.J. Bates, J. Nairn & R.G. Ryall. (2009) Longitudinal Study of Lipoprotein(a) in Peripubertal Children with Insulin‐dependent Diabetes. Diabetic Medicine 12:6, pages 508-512.
Crossref
Crossref
R. W. James, M. Boemi, C. Sirolla, L. Amadio, P. Fumelli & D. Pometta. (1995) Lipoprotein (a) and vascular disease in diabetic patients. Diabetologia 38:6, pages 711-714.
Crossref
Crossref
A. J. JENKINS & J. D. BEST. (2009) The role of lipoprotein(a) in the vascular complications of diabetes mellitus. Journal of Internal Medicine 237:4, pages 359-365.
Crossref
Crossref
P.‐H. Groop, G.C. Viberti, T.G. Elliott, R. Friedman, A. Mackie, C. Ehnholm, M. Jauhiainen & M.‐R. Taskinen. (2009) Lipoprotein(a) in Type 1 Diabetic Patients with Renal Disease. Diabetic Medicine 11:10, pages 961-967.
Crossref
Crossref
R.E. Gilbert, M.E. Cooper, P.G. McNally, R.C. O'Brien, J. Taft & G. Jerums. (2009) Microalbuminuria: Prognostic and Therapeutic Implications in Diabetes Mellitus. Diabetic Medicine 11:7, pages 636-645.
Crossref
Crossref
Steven M. Haffner, Myrto Frangos, Joseph Williamson, Julio Santiago, Rodolfo Valdez, Gilbert Aldrete, Leena Mykkänen, Katherine K. Gruber & David L. Rainwater. (1994) Lp(a) concentrations and phenotypes in children with insulin-dependent diabetes mellitus. Chemistry and Physics of Lipids 67-68, pages 223-231.
Crossref
Crossref
B. J. HEESEN, B. H. R. WOLFFENBUTTEL, P. B. LEURS, J. P. J. E. SELS, P. P. C. A. MENHEERE, S. E. C. JÄCKLE‐BECKERS & A. C. NIEUWENHUIJZEN KRUSEMAN. (2008) Lipoprotein(a) levels in relation to diabetic complications in patients with non‐insuIin‐dependent diabetes. European Journal of Clinical Investigation 23:9, pages 580-584.
Crossref
Crossref
B.H.R. Wolffenbuttel, P.B. Leurs, J.P.J.E. Sels, G.J.W.M. Rondas‐Colbers, P.P.C.A. Menheere & A.C. Nieuwenhuijzen Kruseman. (2009) Improved Blood Glucose Control by Insulin Therapy in Type 2 Diabetic Patients Has No Effect on Lipoprotein(a) Levels. Diabetic Medicine 10:5, pages 427-430.
Crossref
Crossref
F. S. Nielsen, A. I. Voldsgaard, M. -A. Gall, P. Rossing, E. Hommel, P. Andersen, J. Dyerberg & H. -H. Parving. (1993) Apolipoprotein(a) and cardiovascular disease in Type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 36:5, pages 438-444.
Crossref
Crossref